Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826514 · ClinicalTrials.gov registry record · Phase 2
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
A Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
- 20
- Study locations
NCT00826514 is a Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome that has completed, run by Pfizer. The registered enrollment target is 62 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT00826514, a Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tanezumab
Study Locations (20)
California
- Clinical Innovations, Inc. - Costa Mesa
- Citrus Valley Medical Research Inc. - Glendora
- Atlantic Urological Medical Group Incorporated - Long Beach
- Orange Coast Urology - Newport Beach
- Los Angeles Infertility and Prostatitis Medical Group - Santa Monica
Alabama
- Alabama Research Center, LLC - Birmingham
- The Kirklin Clinic - Birmingham
- University of Alabama Birmingham - Birmingham
Florida
- Specialists in Urology - Bonita Springs
- Specialists in Urology - Naples
- Pinellas Urology, Inc. - St. Petersburg
New York
- Hudson Valley Urology, PC - Kingston
- University Urology Associates - New York
- Hudson Valley Urology, PC - Poughkeepsie
Arizona
- Valley Urologic Associates - Goodyear
- Dedicated Clinical Research - Litchfield Park
Ohio
- Tri-State Urologic Services PSC, Inc. dba The Urology Group - Cincinnati
- Cleveland Clinic - Cleveland
Louisiana
- Regional Urology, LLC - Shreveport
Nebraska
- Quality Clinical Research - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2009-03-25 |
| Est. Completion | 2010-03-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826514
The ClinicalTrials.gov registry entry for NCT00826514 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Prostatitis With Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00826514 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Alabama, Florida.
Frequently Asked Questions
What is clinical trial NCT00826514 about?
NCT00826514 is a clinical study titled "An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis". The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
What is the current status of trial NCT00826514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2009-03-25. Estimated completion is 2010-03-17.
What conditions does trial NCT00826514 study?
This clinical trial studies the following conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome.
What interventions are being tested in trial NCT00826514?
The interventions under investigation include: Placebo (DRUG), Tanezumab (DRUG).
Who is sponsoring clinical trial NCT00826514?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00826514 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.